SUBSEQUENT EVENTS	6 Months Ended
Jun. 30, 2026
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 13 - SUBSEQUENT EVENTS The Company has evaluated subsequent events through August 13, 2026, the date the accompanying condensed consolidated financial statements were available to be issued. Based on this evaluation, no events other than the following have occurred that require disclosure or adjustment to the financial statements as of and for the period ended June 30, 2026. On July 2, 2026, the Company received written notification from The Nasdaq Stock Market LLC confirming that the Company had regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement for continued listing on the Nasdaq Capital Market. As a result, the compliance matter was closed. During the subsequent period, the Company's publicly traded warrants expired in accordance with their terms. As a result, the warrants are no longer exercisable and no warrants remain outstanding under such series. The Company's effective shelf registration statement on Form S-3, providing for the offer and sale of up to $100 million of securities from time to time, remains available to support future capital raising activities, subject to applicable securities laws and market conditions.

SUBSEQUENT EVENTS

6 Months Ended

Jun. 30, 2026

NOTE 13 - SUBSEQUENT EVENTS

The Company has evaluated subsequent events through August 13, 2026, the date the accompanying condensed consolidated financial statements were available to be issued. Based on this evaluation, no events other than the following have occurred that require disclosure or adjustment to the financial statements as of and for the period ended June 30, 2026.

On July 2, 2026, the Company received written notification from The Nasdaq Stock Market LLC confirming that the Company had regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement for continued listing on the Nasdaq Capital Market. As a result, the compliance matter was closed.

During the subsequent period, the Company's publicly traded warrants expired in accordance with their terms. As a result, the warrants are no longer exercisable and no warrants remain outstanding under such series.

The Company's effective shelf registration statement on Form S-3, providing for the offer and sale of up to $100 million of securities from time to time, remains available to support future capital raising activities, subject to applicable securities laws and market conditions.